Cleanspace Holdings Ltd

AU:CSX Australia Medical Devices
Market Cap
$23.92 Million
AU$38.63 Million AUD
Market Cap Rank
#27029 Global
#650 in Australia
Share Price
AU$0.47
Change (1 day)
+0.00%
52-Week Range
AU$0.38 - AU$0.86
All Time High
AU$7.50
About

CleanSpace Holdings Limited designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally. The company offers CleanSpace HALO, which provides an elevated level of respiratory protection in healthcare environments; CleanSpace CST … Read more

Cleanspace Holdings Ltd (CSX) - Net Assets

Latest net assets as of June 2025: AU$19.16 Million AUD

Based on the latest financial reports, Cleanspace Holdings Ltd (CSX) has net assets worth AU$19.16 Million AUD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$27.57 Million) and total liabilities (AU$8.41 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$19.16 Million
% of Total Assets 69.48%
Annual Growth Rate 31.69%
5-Year Change -52.96%
10-Year Change N/A
Growth Volatility 312.58

Cleanspace Holdings Ltd - Net Assets Trend (2016–2024)

This chart illustrates how Cleanspace Holdings Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Cleanspace Holdings Ltd (2016–2024)

The table below shows the annual net assets of Cleanspace Holdings Ltd from 2016 to 2024.

Year Net Assets Change
2024-12-31 AU$19.16 Million +0.30%
2023-12-31 AU$19.10 Million -13.00%
2022-12-31 AU$21.96 Million -26.21%
2021-12-31 AU$29.75 Million -26.95%
2020-12-31 AU$40.73 Million +3.37%
2019-12-31 AU$39.40 Million +940.39%
2018-12-31 AU$3.79 Million -21.50%
2017-12-31 AU$4.82 Million +127.70%
2016-12-31 AU$2.12 Million --

Equity Component Analysis

This analysis shows how different components contribute to Cleanspace Holdings Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 711014100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock AU$33.87 Million 176.78%
Other Comprehensive Income AU$784.39K 4.09%
Other Components AU$1.00 0.00%
Total Equity AU$19.16 Million 100.00%

Cleanspace Holdings Ltd Competitors by Market Cap

The table below lists competitors of Cleanspace Holdings Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Cleanspace Holdings Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 19,102,010 to 19,158,455, a change of 56,445 (0.3%).
  • Net loss of 478,276 reduced equity.
  • Other comprehensive income increased equity by 57,699.
  • Other factors increased equity by 477,022.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income AU$-478.28K -2.5%
Other Comprehensive Income AU$57.70K +0.3%
Other Changes AU$477.02K +2.49%
Total Change AU$- 0.30%

Book Value vs Market Value Analysis

This analysis compares Cleanspace Holdings Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.91x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 17.09x to 1.91x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 AU$0.03 AU$0.47 x
2017-12-31 AU$0.06 AU$0.47 x
2018-12-31 AU$0.05 AU$0.47 x
2019-12-31 AU$0.51 AU$0.47 x
2020-12-31 AU$0.53 AU$0.47 x
2021-12-31 AU$0.39 AU$0.47 x
2022-12-31 AU$0.29 AU$0.47 x
2023-12-31 AU$0.25 AU$0.47 x
2024-12-31 AU$0.25 AU$0.47 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Cleanspace Holdings Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -2.50%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -2.42%
  • • Asset Turnover: 0.72x
  • • Equity Multiplier: 1.44x
  • Recent ROE (-2.50%) is above the historical average (-21.73%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 -93.86% -41.56% 0.92x 2.45x AU$-2.20 Million
2017 -22.73% -14.20% 0.95x 1.69x AU$-1.58 Million
2018 -28.10% -9.48% 1.47x 2.02x AU$-1.44 Million
2019 15.03% 20.85% 0.57x 1.26x AU$1.98 Million
2020 27.96% 22.81% 0.98x 1.25x AU$7.31 Million
2021 -37.92% -84.45% 0.35x 1.29x AU$-14.26 Million
2022 -37.04% -67.24% 0.42x 1.32x AU$-10.33 Million
2023 -16.37% -19.89% 0.60x 1.36x AU$-5.04 Million
2024 -2.50% -2.42% 0.72x 1.44x AU$-2.39 Million

Industry Comparison

This section compares Cleanspace Holdings Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $14,750,885
  • Average return on equity (ROE) among peers: -315.19%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Cleanspace Holdings Ltd (CSX) AU$19.16 Million -93.86% 0.44x $14.11 Million
4DMEDICAL Ltd (4DX) $926.64K -85.93% 0.18x $1.08 Billion
Adherium Ltd (ADR) $34.53 Million -3.63% 0.08x $2.37 Million
Aroa Biosurgery Ltd (ARX) $-22.65 Million 0.00% 0.00x $91.94 Million
Atomo Diagnostics Ltd (AT1) $34.48 Million -26.73% 0.05x $8.72 Million
Control Bionics Ltd (CBL) $6.09 Million -15.97% 0.04x $4.72 Million
Cardiex Ltd (CDX) $3.03 Million -101.61% 0.73x $4.25 Million
Compumedics Ltd (CMP) $9.21 Million -30.70% 1.16x $12.44 Million
Cochlear Ltd (COH) $75.42 Million 53.19% 1.13x $6.95 Billion
Cleo Diagnostics Ltd (COV) $5.83 Million -68.54% 0.19x $23.23 Million
Conneqt Health Limited (CQT) $633.50K -2871.98% 13.72x $4.66 Million